Also glutamate decarboxylase, which is rate-limiting for GABA production and was recently assigned important roles in small-cell lung cancer [39], shows increased expression in several of the resistant cell lines, as does the GSH-dependent ABCC2/MRP2 GS-X drug efflux pump [13]. The gene discussed is ABCC2; the disease is small cell lung carcinoma.